Metraipolis › archive › dc_7f40e5bea810

Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses — Europe PMC PMID:41053004

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41053004
DOI
10.1038/s41408-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-10-08T03:01:12.585Z
SHA-256 of the archived text
30dd18bf1743fa741007ce360b3401b277805528689c784154957a0eceaff3c9
Stable URL of this page
https://metraipolis.com/documento/dc_7f40e5bea810

How to cite

Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses — Europe PMC PMID:41053004 — Europe PMC (en), https://europepmc.org/article/MED/41053004 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7f40e5bea810 (Metraipolis archive dc_7f40e5bea810, sha256 30dd18bf1743fa741007ce360b3401b277805528689c784154957a0eceaff3c9)
BibTeX
@misc{dc7f40e5bea810,
  title = {Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses — Europe PMC PMID:41053004},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41053004},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7f40e5bea810; sha256 30dd18bf1743fa741007ce360b3401b277805528689c784154957a0eceaff3c9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41053004. Agents can read the archived copy with the MCP tool read_document.